KR20070029276A - 인슐린으로 인한 저혈당증을 예방하고 조절하기 위한조성물 및 방법 - Google Patents

인슐린으로 인한 저혈당증을 예방하고 조절하기 위한조성물 및 방법 Download PDF

Info

Publication number
KR20070029276A
KR20070029276A KR1020077002164A KR20077002164A KR20070029276A KR 20070029276 A KR20070029276 A KR 20070029276A KR 1020077002164 A KR1020077002164 A KR 1020077002164A KR 20077002164 A KR20077002164 A KR 20077002164A KR 20070029276 A KR20070029276 A KR 20070029276A
Authority
KR
South Korea
Prior art keywords
glucagon
insulin
administered
hypoglycemia
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020077002164A
Other languages
English (en)
Korean (ko)
Inventor
다니엘 티. 그린
로버트 알. 헨리
Original Assignee
디오벡스, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 디오벡스, 인코포레이티드 filed Critical 디오벡스, 인코포레이티드
Publication of KR20070029276A publication Critical patent/KR20070029276A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020077002164A 2004-06-29 2005-06-27 인슐린으로 인한 저혈당증을 예방하고 조절하기 위한조성물 및 방법 Withdrawn KR20070029276A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58444904P 2004-06-29 2004-06-29
US60/584,449 2004-06-29

Publications (1)

Publication Number Publication Date
KR20070029276A true KR20070029276A (ko) 2007-03-13

Family

ID=35783298

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077002164A Withdrawn KR20070029276A (ko) 2004-06-29 2005-06-27 인슐린으로 인한 저혈당증을 예방하고 조절하기 위한조성물 및 방법

Country Status (11)

Country Link
EP (1) EP1778266A4 (enExample)
JP (1) JP2008505087A (enExample)
KR (1) KR20070029276A (enExample)
CN (1) CN101001638A (enExample)
AU (1) AU2005260025A1 (enExample)
CA (1) CA2571030A1 (enExample)
IL (1) IL180361A0 (enExample)
MX (1) MXPA06014970A (enExample)
NO (1) NO20070174L (enExample)
WO (1) WO2006004696A2 (enExample)
ZA (1) ZA200700708B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012059764A1 (en) 2010-11-03 2012-05-10 Arecor Limited Novel composition comprising glucagon
EP3344231B1 (en) * 2015-09-04 2022-04-13 Latitude Pharmaceuticals, Inc. Stabilized glucagon solutions
GB201611077D0 (en) 2016-06-24 2016-08-10 Arecor Ltd Novel composition
US11357829B2 (en) 2017-02-03 2022-06-14 Vanderbilt University Systems, compositions and methods for treating diabetes
BR112020000447A2 (pt) * 2017-07-14 2020-07-21 Xeris Pharmaceuticals, Inc. métodos de tratamento de hiperinsulinismo congênito
WO2019108640A1 (en) * 2017-11-28 2019-06-06 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods and kits for evaluating metabolism
EP4171509A1 (en) * 2020-06-26 2023-05-03 Xeris Pharmaceuticals, Inc. Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same
GB202109087D0 (en) * 2021-06-24 2021-08-11 Norwegian Univ Sci & Tech Ntnu Therapeutic methods and devices

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897551A (en) * 1971-04-05 1975-07-29 Lilly Co Eli Iodoglucagons and process for prolonging the biological activity of glucagon
US5321008A (en) * 1991-01-10 1994-06-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
JP2006508975A (ja) * 2002-11-18 2006-03-16 ファイザー・プロダクツ・インク ジペプチジルペプチダーゼｉｖを阻害するフッ素化環状アミド
NZ541365A (en) * 2002-12-27 2009-09-25 Diobex Inc Compositions and methods for the prevention and control of insulin-induced hypoglycemia

Also Published As

Publication number Publication date
NO20070174L (no) 2007-03-13
ZA200700708B (en) 2009-03-25
AU2005260025A1 (en) 2006-01-12
IL180361A0 (en) 2007-06-03
EP1778266A4 (en) 2009-09-09
WO2006004696A2 (en) 2006-01-12
CA2571030A1 (en) 2006-01-12
JP2008505087A (ja) 2008-02-21
EP1778266A2 (en) 2007-05-02
MXPA06014970A (es) 2007-03-07
CN101001638A (zh) 2007-07-18
WO2006004696A3 (en) 2006-10-26

Similar Documents

Publication Publication Date Title
US7655618B2 (en) Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US7314859B2 (en) Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US20230148019A1 (en) Use of ultrarapid acting insulin
JP2006514990A5 (enExample)
US20220152160A1 (en) Dosing regimen
WO2014177623A1 (en) Novel administration regime
JP2008505087A (ja) インスリン誘発性低血糖の予防および制御のための組成物ならびに方法
HK1108567A (en) Compositions and methods for the prevention and control of insulin-induced hypoglycemia
ZA200504944B (en) Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US20230158116A1 (en) Use of human amylin analog polypeptides for providing superior glycemic control to type 1 diabetics
HK1085123A (en) Compositions and methods for the prevention and control of insulin-induced hypoglycemia

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20070129

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid